Merck CEO Kenneth Frazier is deploying his deal team this year with some very specific instructions to step up their game. Speaking to an investor group, the CEO made it clear that the pharma giant needs more deals to add new therapies to the pipeline. And he's particularly interested in roping some new hepatitis C programs.
http://www.fiercebiotech.com/story/merck-ceo-frazier-future-industry-going-be-more-partnerships/2012-01-05
bluebush
merck looking for new hepatitis c programs
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $34.28M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $26.06K | 672.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 104334 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 230121 | 4 |
View Market Depth
| Last trade - 14.49pm 02/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |